Organised by the FIP Industrial Pharmacy Section
Chair(s)
Mr Sola Solarin, ExCo member, FIP Industrial Pharmacy Section, Nigeria & Mr Mustafa Abacioglu, ExCo associate, FIP Industrial Pharmacy Section, Turkiye
Introduction:
MANUFACTURING FORWARD – DRIVING PERFORMANCE, FOSTERING COLLABORATION, AND CATALYSING TRANSFORMATION
In alignment with the overarching theme of the FIP World Congress 2025, “Pharmacy Forward: Performance, Collaboration, and Health Transformation,” this workshop on Good Manufacturing Practice (GMP) will explore the critical role GMP plays in shaping the future of pharmacy and healthcare systems. As healthcare systems worldwide strive for sustainability, efficiency, and personalization, GMP stands at the forefront of ensuring product quality, safety, and compliance in the production of pharmaceuticals. Through the lens of the congress subthemes, this workshop will delve into how GMP can contribute to sustainable practices, enhance system performance, and support the delivery of personalised, patient-centered care.
Attendees will gain insights into the evolving landscape of GMP, its intersection with emerging technologies like digital health, and its vital role in advancing global health outcomes.
Programme:
| 09:00 – 09:30 | Keynote address: GMP trends – The future of drug manufacturing |
| Kaushik Desai, FIP Industrial Pharmacy Section Executive Committee Member | |
| 09:30 – 10:15 | Pharma 4.0™: An evolution, not a revolution, in GMP data-based decision making |
| Dennis Hall, MBA – Vice President, Advanced Manufacturing Technologies at US Pharmacopeia | |
| 10:15 – 10:45 | Tea break and networking |
| 10:45 – 11:15 | Regulatory harmonization | |
| Igor Linhares de Castro – FIP Industrial Pharmacy Section President | |
| 11:15 – 11:45 | Supply chain security & OMCLs |
| Prof. Bouchra Meddah - FIP Industrial Pharmacy Section Executive Committee Member | |
| 11:45 – 12:15 | Manufacturing innovative delivery systems: Bench to market challenges |
| Fabio Elefante – Associate Project Director of Stem Cell R&D Devices at Novo Nordisk | |
| 12:15 – 12:45 | Panel discussion with morning speakers |
| 12:45 – 13:30 | Lunch break |
| 13:30 – 14:15 | Addressing supply chain resilience and mitigating drug shortages |
| Dr. Jude Nwokike, Vice President, Supply Chain Resilience at U.S. Pharmacopeia, USA | |
| 14:15 – 14:45 | Regulating new technologies: GMP challenges for regulators and pharmaceutical companies |
| Melanie Dumarey – Product and Process Design Engineer (Associate Principal Scientist) at AstraZeneca | |
| 14:45 – 15:30 | Facilitating access to personalized medicines: compounding and new medicine modalities |
| Dr. Farah Towfic – Senior Director, Healthcare Quality and Safety Center of Excellence at US Pharmacopeia | |
| 16:00 – 16:35 | Panel discussion with afternoon speakers |
| 16:35 – 16:45 | Closing by the chairs |
Learning objectives:
1. Gain an understanding of the dynamics of GMP and pharmaceutical manufacturing.
2. Keep up to date with the trends and breakthroughs in the field.
3. Connect with and learn from industry leaders.
Registration:
The session is accessible with pre-registration only via the regular congress registration. Costs:
€ 260 members / € 420 non members
